MedTrace Logo

Hydrocodone For Pain Control in First Trimester Surgical Abortion

NCT01330459 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2019-04-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether preoperatively administered hydrocodone/acetaminophen (HC/APAP) reduces pain during a first trimester surgical abortion.

Conditions

Interventions

DRUG

Hydrocodone/acetaminophen

Administration of 2 tablets 5/325mg hydrocodone/acetaminophen 45-90 minutes prior to procedure.

DRUG

Placebo

Administration of 2 tablets methylcellulose (placebo) 45-90 minutes prior to procedure.

DRUG

Ibuprofen

800 mg oral ibuprofen

DRUG

Lorazepam

2 mg oral lorazepam

DRUG

Lidocaine

20 ml 1% buffered lidocaine, injected

Sponsors & Collaborators

  • Planned Parenthood Federation of America

    collaborator OTHER

  • Elizabeth Micks

    lead OTHER

Principal Investigators

  • Elizabeth Micks, MD · Oregon Health and Science University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01330459 on ClinicalTrials.gov